On this episode, Alex explores the role of synthetic data in health care and life sciences with Harry Keen, Co-Founder of Hazy, and Dr. Mark Lambrecht, Global Head of Health and Life Sciences Advisory at SAS. The conversation explores practical use cases for synthetic data in the health ecosystem as well as important limitations and considerations for ensuring security and governance.

A core challenge for all health and life sciences organizations is the fragmented and decentralized nature of their data. Keen and Dr. Lambrecht agree that synthetic data can be used to remove barriers, improve efficiency and test approaches to extract more value from existing data, thereby driving innovation and enhancing patient outcomes. Tune in to hear their advice for all leaders interested in building or growing the utility of synthetic data for their organizations.

Is 2025 a pivotal inflection point for AI in health care? Dr. Connie Lehman, Co-Founder of Clairity, thinks so, and she has strong cause for optimism. Her organization’s software-as-a-medical-device product, Clairity Breast, recently received authorization from the Food and Drug Administration as the first AI platform that predicts a woman’s five-year risk of developing breast cancer.

On this episode, Dr. Lehman shares her journey with Clairity, from the paper she read as a medical student that sparked the idea, to her experience navigating the new domain of image-based risk assessment with the FDA. Her current focus is on implementing the technology through education and advocacy.

Dr. Lehman is passionate about advancing medicine toward risk assessment and disease prevention. Understanding risk empowers patients and their health care providers to choose the best path. Dr. Lehman envisions a future where image-based risk information is accessible and available to improve health outcomes for all.

Can AI empower the doctor-patient bond? Dr. Michael Suk, orthopedic surgeon, visionary leader and innovator, believes it can. In this discussion, he explores how AI can help to free up time for patients and speaks about the current AI adoption, highlighting its use in documentation and clinical decision support. He stresses the need for ethical AI solutions and for clinicians to be involved in the design of technological solutions. The conversation touches on the pioneering lifetime joint replacement warranty, illustrating how forging lasting partnerships can lead to improved outcomes, fewer complications and lower costs. Dr. Suk explains that the next evolution of health care demands a purpose-driven, holistic approach and explores how trust, connection and technology will intersect in the future. Tune in for this thought-provoking discussion that challenges the status quo and focuses on the doctor-patient bond.